Literature DB >> 1708890

Thymic tumorigenesis induced by overexpression of p56lck.

K M Abraham1, S D Levin, J D Marth, K A Forbush, R M Perlmutter.   

Abstract

The lck gene encodes a membrane-associated protein tyrosine kinase (p56lck) that is believed to participate in lymphocyte-specific signal transduction pathways. To investigate the function of this molecule, transgenic mice were generated carrying the wild-type lck gene or a mutated lck gene encoding a constitutively activated form of p56lck (p56lckF505). Transgene expression in thymocytes was achieved in each case using the lck proximal promoter element. Mice expressing high levels of either p56lckF505 or p56lckY505 reproducibly developed thymic tumors. The sensitivity of thymocytes to p56lck-induced transformation suggests that disturbances in lck expression may contribute to the pathogenesis of some human neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708890      PMCID: PMC51576          DOI: 10.1073/pnas.88.9.3977

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Tyr527 is phosphorylated in pp60c-src: implications for regulation.

Authors:  J A Cooper; K L Gould; C A Cartwright; T Hunter
Journal:  Science       Date:  1986-03-21       Impact factor: 47.728

Review 2.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.

Authors:  C L Willman; C C Stewart; T L Longacre; D R Head; R Habbersett; S F Ziegler; R M Perlmutter
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

5.  Participation of CD4 coreceptor molecules in T-cell repertoire selection.

Authors:  H S Teh; A M Garvin; K A Forbush; D A Carlow; C B Davis; D R Littman; R M Perlmutter
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

6.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

7.  Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen.

Authors:  A M Garvin; K M Abraham; K A Forbush; A G Farr; B L Davison; R M Perlmutter
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

8.  Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases.

Authors:  J D Marth; D B Lewis; C B Wilson; M E Gearn; E G Krebs; R M Perlmutter
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

9.  Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase.

Authors:  K E Chaffin; C R Beals; T M Wilkie; K A Forbush; M I Simon; R M Perlmutter
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Interleukin 4 expressed in situ selectively alters thymocyte development.

Authors:  D B Lewis; C C Yu; K A Forbush; J Carpenter; T A Sato; A Grossman; D H Liggitt; R M Perlmutter
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  48 in total

Review 1.  Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.

Authors:  Michelle L Hermiston; Zheng Xu; Ravindra Majeti; Arthur Weiss
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice.

Authors:  M Baker; J Gamble; R Tooze; D Higgins; F T Yang; P C O'Brien; N Coleman; S Pingel; M Turner; D R Alexander
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor.

Authors:  Arvind Rajpal; Yuri A Cho; Biana Yelent; Petra H Koza-Taylor; Dongling Li; Elaine Chen; Michael Whang; Chulho Kang; Thomas G Turi; Astar Winoto
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

4.  Tissue- and site-specific DNA recombination in transgenic mice.

Authors:  P C Orban; D Chui; J D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

5.  Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.

Authors:  John C Cooper; Mingjian Shi; Fu-Yu Chueh; Srividya Venkitachalam; Chao-Lan Yu
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

6.  Replication of Mus dunni endogenous retrovirus depends on promoter activation followed by enhancer multimerization.

Authors:  G Wolgamot; A D Miller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Functional dissection of the lck proximal promoter.

Authors:  J M Allen; K A Forbush; R M Perlmutter
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

8.  A novel animal model of thymic tumour: development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene.

Authors:  Kazunori Kikuchi; Hitoshi Ikeda; Takahiro Tsuchikawa; Takahiro Tsuji; Satoshi Tanaka; Kazunori Fugo; Toshiaki Sugaya; Yuetsu Tanaka; Masatoshi Tateno; Naoki Maruyama; Takashi Yoshiki
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

Review 9.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

10.  Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.

Authors:  Isaac Engel; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.